Research & Literature

Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.

Wehner MR, Linos E, Parvataneni R, et al.

JAMA dermatology 2015; (151(4)):382-8 doi:10.1001/jamadermatol.2014.3307.

Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma.

Sun MT, Wu A, Huilgol SC, Selva D

Ophthalmic plastic and reconstructive surgery 2015; (31(6)):449-51 doi:10.1097/IOP.0000000000000372.

Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.

Kauvar AN, Cronin T, Roenigk R, et al.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2015; (41(5)):550-71 doi:10.1097/DSS.0000000000000296.

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.

Sekulic A, Migden MR, Lewis K, et al.

Journal of the American Academy of Dermatology 2015; (72(6)):1021-6.e8.

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.

Migden MR, Guminski A, Gutzmer R, et al.

The Lancet. Oncology 2015; (16(6)):716-28.

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.

Basset-Seguin N, Hauschild A, Grob JJ, et al.

The Lancet. Oncology 2015; (16(6)):729-36.

Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.

Marzuka AG, Book SE

The Yale journal of biology and medicine 2015; (88(2)):167-79.

Basal cell carcinoma: clinical and pathological features.

Di Stefani A, Chimenti S

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2015; (150(4)):385-91.

Surgical treatment of basal cell carcinoma: an algorithm based on the literature.

Luz FB, Ferron C, Cardoso GP

Anais brasileiros de dermatologia 2015; (90(3)):377-83.

Management of periorbital basal cell carcinoma with orbital invasion.

Sun MT, Wu A, Figueira E, et al.

Future oncology (London, England) 2015; (11(22)):3003-10 doi:10.2217/fon.15.190.

Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes.

Correia de Sá TR, Silva R, Lopes JM

Future oncology (London, England) 2015; (11(22)):3011-21 doi:10.2217/fon.15.246.

The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital.

Takata Pontes L, Fantelli Stelini R, Cintra ML, et al.

Clinics (Sao Paulo, Brazil) 2015; (70(11)):721-5.

Favourable results of Mohs micrographic surgery for basal cell carcinoma.

Gniadecki R, Glud M, Mortensen K, et al.

Danish medical journal 2015; (62(12)):A5171.

Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Bonilla X, Parmentier L, King B, et al.

Nature genetics 2016; (48(4)):398-406 doi:10.1038/ng.3525.

[Exclusive radiotherapy for a facial basal cell carcinoma with trigeminal ganglion involvement].

Longeac M, Lapeyre M, Delbet Dupas C, et al.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2016; (20(4)):308-11.

Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Bichakjian CK, Olencki T, Aasi SZ, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2016; (14(5)):574-97 doi:10.6004/jnccn.2016.0065.

Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population.

Ray GT, Kulldorff M, Asgari MM

JAMA dermatology 2016; (152(11)):1218-1224 doi:10.1001/jamadermatol.2016.2536.

Sun protection for preventing basal cell and squamous cell skin cancers.

Sánchez G, Nova J, Rodriguez-Hernandez AE, et al.

The Cochrane database of systematic reviews 2016; (7()):CD011161 doi:10.1002/14651858.CD011161.pub2.

Management of BCC and SCC of the Head and Neck.

Strom TJ, Caudell JJ, Harrison LB

Cancer control : journal of the Moffitt Cancer Center 2016; (23(3)):220-7 doi:10.1177/107327481602300305.

Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.

Lupu M, Caruntu C, Ghita MA, et al.

Disease markers 2016; (2016()):9831237 doi:10.1155/2016/9831237.

Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.

Newlands C, Currie R, Memon A, et al.

The Journal of laryngology and otology 2016; (130(S2)):S125-S132 doi:10.1017/S0022215116000554.

Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.

Furdova A, Lukacko P

The Journal of craniofacial surgery 2017; (28(1)):e84-e87 doi:10.1097/SCS.0000000000003242.

Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.

Williams HC, Bath-Hextall F, Ozolins M, et al.

The Journal of investigative dermatology 2017; (137(3)):614-619 doi:10.1016/j.jid.2016.10.019.

[The role of dermoscopy in the diagnosis of basosquamous carcinoma].

Elmahi H, Lahlou A, Baybay H, et al.

The Pan African medical journal 2016; (25()):252 doi:10.11604/pamj.2016.25.252.11345.

Detection of High-Risk Histologic Features and Tumor Upstaging of Nonmelanoma Skin Cancers on Debulk Analysis: A Quantitative Systematic Review.

Singh B, Dorelles A, Konnikov N, Nguyen BM

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2017; (43(8)):1003-1011 doi:10.1097/DSS.0000000000001146.

Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.

Jansen MHE, Mosterd K, Arits AHMM, et al.

The Journal of investigative dermatology 2018; (138(3)):527-533 doi:10.1016/j.jid.2017.09.033.

Perineural spread of basosquamous carcinoma to the orbit, cavernous sinus, and infratemporal fossa.

Amram AL, Hertzing WJ, Smith SV, et al.

Orbit (Amsterdam, Netherlands) 2018; (37(2)):110-114 doi:10.1080/01676830.2017.1383462.

Understanding the Molecular Genetics of Basal Cell Carcinoma.

Pellegrini C, Maturo MG, Di Nardo L, et al.

International journal of molecular sciences 2017; (18(11)) doi:10.3390/ijms18112485.

Guidelines of care for the management of basal cell carcinoma.

, , Kim JYS, et al.

Journal of the American Academy of Dermatology 2018; (78(3)):540-559 doi:10.1016/j.jaad.2017.10.006.

Patient Indications for Mohs Micrographic Surgery: A Systematic Review.

Murray C, Sivajohanathan D, Hanna TP, et al.

Journal of cutaneous medicine and surgery 2019; (23(1)):75-90 doi:10.1177/1203475418786208.

A Rare Report of Lung Metastasis of the Common Non-Melanotic Skin Cancer.

Shafiepour M, Kiani A, Taghavi K, et al.

Tanaffos 2018; (17(1)):62-65.

Current Basal and Squamous Cell Skin Cancer Management.

Mendez BM, Thornton JF

Plastic and reconstructive surgery 2018; (142(3)):373e-387e doi:10.1097/PRS.0000000000004696.

Mohs Micrographic Surgery.

Wong E, Axibal E, Brown M

Facial plastic surgery clinics of North America 2019; (27(1)):15-34 doi:10.1016/j.fsc.2018.08.002.

Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.

Weesie F, Naus NC, Vasilic D, et al.

The British journal of dermatology 2019; (180(5)):1176-1182 doi:10.1111/bjd.17516.

Mixed cranial neuropathies due to occult perineural invasion of basal cell carcinoma.

Ashraf DC, Kalin-Hajdu E, Levin MH, Kersten RC

American journal of ophthalmology case reports 2019; (13()):136-139 doi:10.1016/j.ajoc.2018.12.018.

Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.

Venables ZC, Nijsten T, Wong KF, et al.

The British journal of dermatology 2019; (181(3)):474-482 doi:10.1111/bjd.17873.

Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.

Santos-Arroyo A, Carrasquillo OY, Cardona R, et al.

Puerto Rico health sciences journal 2019; (38(1)):40-45.

Depth of Invasion of Aggressive and Nonaggressive Basal Cell Carcinoma.

Wetzel M, Strickley J, Haeberle MT, Brown TS

The Journal of clinical and aesthetic dermatology 2019; (12(3)):12-14.

Nonsurgical Options for the Treatment of Basal Cell Carcinoma.

Paoli J, Gyllencreutz JD, Fougelberg J, et al.

Dermatology practical & conceptual 2019; (9(2)):75-81 doi:10.5826/dpc.0902a01.

Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.

Gutzmer R, Solomon JA

Targeted oncology 2019; (14(3)):253-267 doi:10.1007/s11523-019-00648-2.

Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened.

Pietrobono S, Gagliardi S, Stecca B

Frontiers in genetics 2019; (10()):556 doi:10.3389/fgene.2019.00556.

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.

Peris K, Fargnoli MC, Garbe C, et al.

European journal of cancer (Oxford, England : 1990) 2019; (118()):10-34 doi:10.1016/j.ejca.2019.06.003.

Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.

Dummer R, Guminksi A, Gutzmer R, et al.

The British journal of dermatology 2020; (182(6)):1369-1378 doi:10.1111/bjd.18552.

Approaches to Perineural, Lymphovascular, and Single-Cell Disease.

Collins MK, Behshad R, Maloney M, Pugliano-Mauro M

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2019; (45 Suppl 2()):S118-S128 doi:10.1097/DSS.0000000000002259.

Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.

Likhacheva A, Awan M, Barker CA, et al.

Practical radiation oncology 2020; (10(1)):8-20 doi:10.1016/j.prro.2019.10.014.

Cumulative solar ultraviolet radiation exposure and basal cell carcinoma of the skin in a nationwide US cohort using satellite and ground-based measures.

Little MP, Linet MS, Kimlin MG, et al.

Environmental health : a global access science source 2019; (18(1)):114 doi:10.1186/s12940-019-0536-9.

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.

Stratigos AJ, Garbe C, Dessinioti C, et al.

European journal of cancer (Oxford, England : 1990) 2020; (128()):60-82 doi:10.1016/j.ejca.2020.01.007.

Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics.

Bisceglia M, Panniello G, Galliani CA, et al.

Advances in anatomic pathology 2020; (27(5)):331-353 doi:10.1097/PAP.0000000000000267.

Biopsy outperforms reflectance confocal microscopy in diagnosing and subtyping basal cell carcinoma: results and experiences from a randomized controlled multicentre trial.

Woliner-van der Weg W, Peppelman M, Elshot YS, et al.

The British journal of dermatology 2021; (184(4)):663-671 doi:10.1111/bjd.19381.

Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.

Firnhaber JM

American family physician 2020; (102(6)):339-346.

Line-field confocal optical coherence tomography of basal cell carcinoma: a descriptive study.

Suppa M, Fontaine M, Dejonckheere G, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(5)):1099-1110 doi:10.1111/jdv.17078.

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.

Stratigos AJ, Sekulic A, Peris K, et al.

The Lancet. Oncology 2021; (22(6)):848-857 doi:10.1016/S1470-2045(21)00126-1.

A review of emerging and non-US FDA-approved topical agents for the treatment of basal cell carcinoma.

Kash N, Silapunt S

Future oncology (London, England) 2021; (17(23)):3111-3132 doi:10.2217/fon-2020-1147.

Known and new facts on basal cell carcinoma.

Seidl-Philipp M, Frischhut N, Höllweger N, et al.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2021; (19(7)):1021-1041 doi:10.1111/ddg.14580.

Trends of cutaneous basal cell carcinoma, squamous cell carcinoma, and melanoma among the Chinese, Malays, and Indians in Singapore from 1968-2016.

Oh CC, Jin A, Koh WP

JAAD international 2021; (4()):39-45 doi:10.1016/j.jdin.2021.05.006.

Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis.

An S, Kim K, Moon S, et al.

Cancers 2021; (13(23)) doi:10.3390/cancers13235940.

Position paper on a simplified histopathological classification of basal cell carcinoma: results of the European Consensus Project.

Fernández-Figueras MT, Malvehi J, Tschandl P, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(3)):351-359 doi:10.1111/jdv.17849.

Photoprotection for Skin of Color.

Tsai J, Chien AL

American journal of clinical dermatology 2022; (23(2)):195-205 doi:10.1007/s40257-021-00670-z.

Micrographic dermatologic surgery (MDS) diplomates: a demographic evaluation and comparison of Medicare case volume.

Walocko FM, Memon R, Kwasny MJ

Archives of dermatological research 2022; (314(2)):213-216 doi:10.1007/s00403-022-02329-z.

Histologically Agressive Basal Cell Carcinoma With Particular Emphasis On Galeal Infiltration Of The Scalp.

Requena C, Serra-Guillén C, Sanmartín O

Actas dermo-sifiliograficas 2022; (113(6)):575-582 doi:10.1016/j.ad.2022.01.026.

Advanced basal cell carcinoma: What dermatologists need to know about treatment.

Wilson M, Johnson RP, Senft SC, et al.

Journal of the American Academy of Dermatology 2022; (86(6S)):S14-S24 doi:10.1016/j.jaad.2022.03.022.

Complete Margin Assessment Versus Sectional Assessment in Surgically Excised High-Risk Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis.

Fraga SD, Besaw RJ, Murad F, et al.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2022; (48(7)):704-710 doi:10.1097/DSS.0000000000003462.

Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma.

Chen OM, Kim K, Steele C, et al.

Cancers 2022; (14(15)) doi:10.3390/cancers14153720.

Basal Cell Carcinoma With Perineural Invasion: A Systematic Review and Pooled Survival Analysis.

Abushukur Y, Ibrahim Y, Cascardo C, et al.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2022; (48(11)):1159-1165 doi:10.1097/DSS.0000000000003593.

Basal Cell Carcinoma.

Heath MS, Bar A

Dermatologic clinics 2023; (41(1)):13-21 doi:10.1016/j.det.2022.07.005.

Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines.

Ligeralde-Bascones KI, Gulmatico-Flores Z, Lim-Bueser HG, et al.

International journal of dermatology 2023; (62(6)):812-821 doi:10.1111/ijd.16555.

Adequacy of surgical margins, re-excision, and evaluation of factors associated with recurrence: a retrospective study of 769 basal cell carcinomas.

Gürsel Ürün Y, Can N, Bağış M, et al.

Anais brasileiros de dermatologia 2023; (98(4)):449-459 doi:10.1016/j.abd.2022.07.005.

A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer.

Navarro-Bielsa A, Gracia-Cazaña T, Almagro M, et al.

Photodermatology, photoimmunology & photomedicine 2023; (39(5)):457-465 doi:10.1111/phpp.12878.

Basal Cell Carcinoma Perineural Invasion and Suggestive Signs of Perineural Invasion-Findings and Perspectives.

Niculet E, Bobeica C, Onisor C, et al.

Life (Basel, Switzerland) 2023; (13(6)) doi:10.3390/life13061406.

Superficial Basal Cell Carcinoma on the Back Region Treated with a Combination of Cryotherapy and 5% Imiquimod Cream: A Case Report.

Sutedja EK, Elgianda GS, Sutedja E, Ruchiatan K

International medical case reports journal 2023; (16()):391-396 doi:10.2147/IMCRJ.S409840.

Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer.

Hyeraci M, Papanikolau ES, Grimaldi M, et al.

Biomolecules 2023; (13(7)) doi:10.3390/biom13071067.

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.

Peris K, Fargnoli MC, Kaufmann R, et al.

European journal of cancer (Oxford, England : 1990) 2023; (192()):113254 doi:10.1016/j.ejca.2023.113254.

Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment.

Dessinioti C, Stratigos AJ

Dermatology practical & conceptual 2023; (13(4)) doi:10.5826/dpc.1304a252.

Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review.

Conte S, Ghezelbash S, Nallanathan B, Lefrançois P

Current oncology (Toronto, Ont.) 2023; (30(11)):9906-9928 doi:10.3390/curroncol30110720.

Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.

Hoashi T, Ishikawa M, Uehara J, et al.

The Journal of dermatology 2024; (51(4)):e90-e105 doi:10.1111/1346-8138.16944.

Mohs micrographic technique in high-risk basal cell carcinoma: a 3D prediction of safety margins.

Cammarata E, Esposto E, Airoldi C, et al.

Journal of wound care 2024; (33(Sup8a)):cxciv-cxcviii doi:10.12968/jowc.2020.0322.

Frequent Occurrence of High-Risk Basal Cell Carcinoma in Xeroderma Pigmentosum: A Histopathological Insight From an Indian Cohort.

Imran S, Dagar S, Ahuja R, et al.

Journal of cutaneous pathology 2025; (52(2)):154-161 doi:10.1111/cup.14753.

Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA).

Xu YG, Lim Y, Bordeaux JS, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2024; (22(9)).

10 Years of Mohs Micrographic Surgery in Denmark: Results from a Nationwide Cohort.

Andersen YMF, Karmisholt K, Høgsberg T, et al.

Acta dermato-venereologica 2025; (105()):adv41118 doi:10.2340/actadv.v105.41118.

Managing Advanced Basal Cell Carcinoma: A Guide for the Dermatology Clinician.

Burshtein J, Schlesinger T

The Journal of clinical and aesthetic dermatology 2025; (18(3)):21-27.

Correlation of dermoscopic and histopathological features in basal cell carcinoma using computerized image analysis.

Kaya G, Ataman K, Güleşçi S, Yabaci Tak A

Frontiers in medicine 2025; (12()):1581601 doi:10.3389/fmed.2025.1581601.

Margins in head and neck non-melanoma skin cancer surgery: clinical/pathological criteria and their impact on oncological outcomes and therapeutic choices. A systematic review.

Bussu F, Daloiso A, Pagliuca G, et al.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2025; (45(Suppl. 1)):S121-S136 doi:10.14639/0392-100X-suppl.1-45-2025-N1121.

Metastatic basal cell carcinoma: Case series and literature review.

Rodrigues MG, de Lucena AV, Domingues GA, et al.

Brazilian journal of otorhinolaryngology 2025; (91 Suppl 1()):101619 doi:10.1016/j.bjorl.2025.101619.

Clinical Features and Outcomes of Locally Advanced and Metastatic Basal Cell Carcinoma.

Zwanenburg AAJH, Van Houdt WJ, Schrijver AM, et al.

Acta dermato-venereologica 2025; (105()):adv43240 doi:10.2340/actadv.v105.43240.

How Perfectly Do Biopsy Request Forms and Pathology Reports Adhere to Guidelines in Basal Cell Carcinoma? A Retrospective Analysis of 851 Cases.

Altınöz Güney C, Koç HA, Çınar E

Journal of cutaneous pathology 2026; (53(6)):524-531 doi:10.1111/cup.70094.

Assessment of high- and low-risk histopathologic subtypes of basal cell carcinoma using artificial intelligence and dermatologist evaluation.

Liang V, Shahrouki P, Nejad D, et al.

JAAD international 2026; (26()):103-112 doi:10.1016/j.jdin.2026.03.014.

Beyond the scalpel: rare and experimental nonsurgical treatments for basal cell carcinoma.

Deng E, Khachemoune A

Dermatology online journal 2026; (31(6)) doi:10.25251/z041c253.

Global, regional and national burden of skin cancer from 1990 to 2021: Analysis of risk factors and prediction of trends in 2035.

Sun H, Fu J, Li J, et al.

Medicine 2026; (105(27)):e49407 doi:10.1097/MD.0000000000049407.